PLXNA1 and cancer: Notably, PLXNA1, PLXNA3, and PTK7 are abundantly expressed in multiple cancer types, primarily correlated with aggressive phenotypes and poor prognosis (Jin et al., 2014; Woischke et al., 2016; Zhang, Shao, & Li, 2020).